Abstract: An apparatus comprises a mould part having a forming chamber and a filling device for filling the forming chamber with a mouldable material. The filling device comprises an entry duct for a flow of mouldable material and air and a preliminary chamber communicating with the forming chamber. The entry duct opens into the preliminary chamber in a position such as to send the flow of mouldable material and air towards the forming chamber with a helicoidal movement, so as to separate the mouldable material from the air.

Abstract: A liquid pharmaceutical solution having antimicrobial agent(s), an organic solvent, and an acidic or basic aqueous medium therein. Most preferred solutions include trimethoprim, sodium hydroxide, sulfadiazine, N-methylpyrrolidone and water. The present invention is also directed toward making these solutions. A most preferred composition includes: trimethoprim in an amount of about 40 mg/ml of liquid pharmaceutical solution; sulfadiazine in an amount of about 200 mg/ml of liquid pharmaceutical solution; N-methylpyrrolidone in an amount of about 514 mg/ml of liquid pharmaceutical solution, sodium hydroxide in an amount of about 30 mg/ml of liquid pharmaceutical solution and water. Methods of making the pharmaceutical solution preferably include combining the following in any order: trimethoprim, N-methylpyrrolidone, sulfadiazine, and an acidic or basic aqueous medium. Other additives, such as antioxidants and preservatives, can also be added to the liquid pharmaceutical solution.

Abstract: Process for recycling flexible foams by glycolysis and extraction. The glycolysis is conducted by allowing the foam to react with low molecular weight polyols, then allowing the mixture to separate in two phases.

Abstract: Process for recycling flexible foams by glycolysis and extraction. The glycolysis is conducted by allowing the foam to react with low molecular weight polyols, then allowing the mixture to separate in two phases.

Abstract: The level of unsaturation in certain polyols can be reduced by extraction with certain low molecular weight polyols like ethylene glycol.

Abstract: Compounds of general formula I ##STR1## wherein R.sup.2 is hydrogen unsubstituted C.sub.1 -C.sub.6 alkyl or C.sub.1 -C.sub.6 alkyl substituted by --OH, --CN or by --Si(OR.sup.3).sub.3-q R.sup.4.sub.q, or C.sub.2 -C.sub.6 alkenyl,R.sup.3 is C.sub.1 -C.sub.4 alkyl, or two radicals R.sup.3 together are C.sub.1 -C.sub.4 alkylene,R.sup.4 is C.sub.1 -C.sub.4 alkyl or phenyl, andq is from 0 to 2, andE is a radical of the formula ##STR2## wherein R.sup.5 is hydrogen or C.sub.1 -C.sub.4 alkyl andR.sup.6 is hydrogen, orR.sup.5 and R.sup.6 together are C.sub.4 -C.sub.8 alkylene, orandA is --(CH.sub.2).sub.r --O--, wherein r is 1,2 or 3, and p is 0 or 1, andY is oxygen or sulfur; andwhereinT is a radical --R.sup.9 --Si(OR.sup.3).sub.3-q R.sup.4.sub.q, a radical of the formula ##STR3## X is --S-- or --NH--, and Z is an organic radical derived from a polyisocyanate or polyisothiocyanate having at least 2 NCO or NCS groups, respectively,are suitable as adhesion promoters, especially for moisture-curing polyurethane resins.

Abstract: Novel iminosilanes of the general formula Ia or Ib ##STR1## in which R.sub.1 is alkyl, cycloalkyl or aralkyl containing at least on the .alpha.-C atom substituents which are inert towards isocyanate groups, so that no hydrogen atom is present on this C atom, R.sub.2 is as defined for R.sub.1 or is hydrogen, or R.sub.1 and R.sub.2 , together with the common C atom, form a cyclohexylene ring which has on the two C atoms substituents which are inert towards isocyanate groups, R.sub.3 to R.sub.7 are organic radicals, p is 0,1 or 2, m is 1 or 2, n is an integer from 1 to 5 and X is --S-- or --NH--, are described.

Abstract: Compounds of the general formula I ##STR1## wherein R.sub.1 is hydrogen, C.sub.1 -C.sub.12 alkyl, C.sub.5 -C.sub.7 cycloalkyl, phenyl or benzyl,R.sub.2 is hydrogen or C.sub.1 -C.sub.4 alkyl, orR.sub.1 and R.sub.2, together with the linking carbon atom, form a 5- or 6-membered ring, andR.sub.3, R.sub.4, R.sub.5 and R.sub.6 are identical or different and are hydrogen, C.sub.1 -C.sub.12 alkyl, phenyl or phenyl substituted by 1 to 3 members selected from the group consisting of C.sub.1 -C.sub.4 alkyl, halogen or C.sub.1 -C.sub.4 alkoxy or are a group of formula --CH.sub.2 OR.sub.11, where R.sub.11, where R.sub.11 is C.sub.1 -C.sub.12 alkyl, phenyl or phenyl substituted by 1 to 3 members selected from the group consisting of C.sub.1 -C.sub.4 alkyl, halogen or C.sub.1 -C.sub.4 alkoxy, or are --C(O)--R.sub.12, and R.sub.12, and R.sub.12 is C.sub.1 -C.sub.12 alkyl,R.sub.7 is C.sub.1 -C.sub.4 alkylene, R.sub.8 is C.sub.1 -C.sub.8 alkylene, R.sub.9 is C.sub.1 -C.sub.4 alkyl, or two radicals R.sub.9 together are C.sub.

Abstract: Compounds of the general formula I ##STR1## wherein R.sub.1 is a hydrogen, C.sub.1 -C.sub.12 alkyl, C.sub.5 -C.sub.7 cycloalkyl, phenyl or benzy.,R.sub.2 is hydrogen or C.sub.1 -C.sub.4 alkyl, orR.sub.1 and R.sub.2, together with the linking carbon atom, form a 5- or 6-membered ring, andR.sub.3, R.sub.4, R.sub.5 and R.sub.6 are identical or different and are hydrogen, C.sub.1 -C.sub.12 alkyl, phenyl or phenyl substituted by 1 to 3 members selected from the group consisting of C.sub.1 -C.sub.4 alkyl, halogen or C.sub.1 -C.sub.4 alkoxy or are a group of formula --CH.sub.2 OR.sub.11, where R.sub.11 is C.sub.1 -C.sub.12 alkyl, phenyl or phenyl substituted by 1 to 3 members selected from the group consisting of C.sub.1 -C.sub.4 alkyl, halogen or C.sub.1 -C.sub.4 alkoxy, or are --C(O)-R.sub.12, and R.sub.12 is C.sub.1 -C.sub.12 alkyl,R.sub.7 is C.sub.1 -C.sub.4 alkylene, R.sub.8 is C.sub.1 -C.sub.8 alkylene, R.sub.9 is C.sub.1 -C.sub.4 alkyl, or two radicals R.sub.9 together are C.sub.1 -C.sub.4 alkylene, and R.